Additional information
Brown Powder; Hygroscopic
865792-18-3
ACI-037811
NA
C31H45N9O2
575.75
Ambient
2-8°C
Anti-stroke agent
Pharmaceutical Impurity Standards
1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one
1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one
6-[4-(1-cyclohexyl-1H-1,2,3,4-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-1,2,3,4-tetrazol-5-yl)butyl]-1,2,3,4-tetrahydroquinolin-2-one





![6,9-DIACYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-Acetoxy-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,9-diyl (2R,2'R,3S,3'S)-bis(3-benzamido-2-hydroxy-3-phenylpropanoate))](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)